Delivery Order SPE2DB24D8001-SPE2DB24FKZCC

Award Date 9/24/24
Potential Completion Date 9/25/24
Potential Value $3.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the procurement of 0.25 mg/0.5 mL pens of the pharmaceutical product WEGOVY. The contract has a ceiling value of $3,634.12 and a performance period ending on January 3, 2025. This contract award is part of Dakota Drug, Inc.'s existing Indefinite Delivery Contract (IDC) SPE2DB24D8001, valued at $999,999,999.00, which allows the company to...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the purchase of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has a total ceiling value of $15,933.58 and a period of performance through November 18, 2024. Dakota Drug, Inc. holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division under the ECAT Generation V...
This federal contract award, with ID SPE2DX15D8001|SPE2DX24FBQYK, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $6,791.06 firm fixed-price delivery order is for the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, with a completion date of May 21, 2024. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. Department of Defense. The company holds...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $1,286.46 to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML pharmaceutical products. This contract, identified as SPE2DB24D8001, is part of the DLA Troop Support Medical's ECAT Generation V Program, which enables Dakota Drug, Inc. to provide a broad range of pharmaceutical and medical supplies to support U.S. Armed Forces medical operations. The...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,938.23 firm fixed-price contract is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a prescription pharmaceutical product. The contract has a performance period through February 12, 2024. Dakota Drug, Inc. also holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the procurement of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The total ceiling value of the contract is $3,954.56, with a period of performance through December 18, 2023. This order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, identified as SPE2DB24D8001, valued at...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of the pharmaceutical product WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of June 4, 2024 and a ceiling value of $1,895.80. The contract was awarded on June 3, 2024 and does not have a set-aside designation. Dakota Drug, Inc. is an experienced prime contractor...
This is a firm fixed-price delivery order contract awarded by the Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $12,207.48, is for the supply of the prescription drug WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. The contract has a period of performance ending on May 21, 2024 and was awarded on May 20, 2024. This contract is not set aside for any specific business type. Dakota Drug,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML pharmaceutical products. The contract has a firm fixed price pricing type, a ceiling value of $4,822.96, and a period of performance through January 7, 2025. Dakota Drug, Inc. is a key supplier for the DLA Troop Support Medical division, holding a single-award Indefinite Delivery...
This is a firm fixed-price delivery order awarded by the U.S. Department of Defense's Medical Supply Chain organization (also known as the Defense Logistics Agency (DLA) Troop Support Medical) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $4,897.22 contract is for the delivery of WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, a prescription medication, with a performance period ending on April 25, 2024. The contract was awarded on...
  • SPE2DB24D8001
    Indefinite Delivery Contract
  • SPE2DB24D8001-SPE2DB24FKZCC
    Delivery Order

This federal contract award, valued at $3,071.33, was issued by the Defense Logistics Agency (DLA) to the prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is a delivery order for the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, which has an ultimate completion date of September 25, 2024.

Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, under the DLA Troop Support Medical's ECAT Generation V Program. This IDC allows the company to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The contract does not have a set-aside designation.

Generated 12/24/24, 9:28 AM